Long-term results of gemcitabine plus oxaliplatin with and without rituximab as salvage treatment for transplant-ineligible patients with refractory/relapsing B-cell lymphoma

Author： Corazzelli Gaetano   Capobianco Gaetana   Arcamone Manuela   Ballerini Pier   Iannitto Emilio   Russo Filippo   Frigeri Ferdinando   Becchimanzi Cristina   Marcacci Gianpaolo   Chiara Annarosaria   Pinto Antonio  

Publisher： Springer Publishing Company

ISSN： 0344-5704

Source： Cancer Chemotherapy and Pharmacology, Vol.64, Iss.5, 2009-10, pp. : 907-916

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Gemcitabine, oxaliplatin and dexamethasone as salvage treatment for elderly patients with refractory and relapsed peripheral T-cell lymphoma

By Yao Yi-yun   Tang Yong   Zhu Qi   Zhuang Yan   Cheng Yi-min   Wang Lei   Zou Li-fang  

Leukemia and Lymphoma, Vol. 54, Iss. 6, 2013-06 ,pp. : 1194-1200

Informa Healthcare

Access to resources Recommend Favorite

Long-term follow-up of localized, primary gastric diffuse large B-cell lymphoma treated with rituximab and CHOP

By                                    

Experimental and Therapeutic Medicine, Vol. 3, Iss. 2, 2012-01 ,pp. : 304-308

Spandidos Publications

Access to resources Recommend Favorite

Preliminary outcome of rituximab-containing salvage regimens on relapsed or refractory B-cell non-Hodgkin’s lymphoma: single institution experience

By Wang Bufei   Huang Huiqiang   Bu Qing   Xia Zhongjun   Lin Xubin   Wang Fenghua   Li Yuhong   Peng Yulong   Pan Zhanhe   Wang Shusen   Lin Tongyu   Jiang Wenqi   Guan Zhongzhen  

The Chinese-German Journal of Clinical Oncology, Vol. 5, Iss. 6, 2006-12 ,pp. : 402-406

Springer Publishing Company

Access to resources Recommend Favorite

Dexamethasone, High-Dose Cytarabine, and Cisplatin in Combination with Rituximab as Salvage Treatment for Patients with Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma

By Mey Ulrich   Orlopp Katjana   Flieger Dimitri   Strehl John   Ho Anthony   Hensel Manfred   Bopp Cordula   Gorschlüter Marcus   Wilhelm Martin   Birkmann Josef   Kaiser Ulrich   Neubauer Andreas   Florschütz Axel   Rabe Christian   Hahn Corinna   Glasmacher Axel   Schmidt-Wolf Ingo  

Cancer Investigation, Vol. 24, Iss. 6, 2006-09 ,pp. : 593-600

Informa Healthcare

Access to resources Recommend Favorite

Phase III study of ACVBP versus ACVBP plus rituximab for patients with localized low-risk diffuse large B-cell lymphoma (LNH03-1B)

By Ketterer N.   Coiffier B.   Thieblemont C.   Ferm C.   Brire J.   Casasnovas O.   Bologna S.   Christian B.   Connerotte T.   Rcher C.   Bordessoule D.   Fruchart C.   Delarue R.   Bonnet C.   Morschhauser F.   Anglaret B.   Soussain C.   Fabiani B.   Tilly H.   Haioun C.  

Annals of Oncology, Vol. 24, Iss. 4, 2013-04 ,pp. : 1032-1037

Oxford University Press

Access to resources Recommend Favorite